VU FCHG prof. (HP) dr. Almira Ramanavičienė and her foreign partners have won the HORIZON-MSCA-SE project "Transforming chronic wound care with targeted MXene-based antibacterial and regenerative technologies" (MX-WOUND), which will be implemented over the next four years.

 

This project is dedicated to the creation of a new generation of multifunctional antibacterial platforms based on MXenes for targeted wound treatment and regenerative therapy. Scientists will seek to offer innovative solutions and overcome challenges related to chronic wound infections caused by bacteria that are resistant to many drugs.

 

Congratulations and we wish good luck!